Kurs
+5,43%
Likviditet
0,25 MSEK
Kalender
Est. tid* | ||
2025-05-15 | N/A | X-dag ordinarie utdelning REDS 0.00 SEK |
2025-05-14 | N/A | Årsstämma |
2025-05-14 | 08:30 | Kvartalsrapport 2025-Q1 |
2025-02-26 | - | Bokslutskommuniké 2024 |
2024-11-26 | - | Kvartalsrapport 2024-Q3 |
2024-08-29 | - | Kvartalsrapport 2024-Q2 |
2024-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2024-05-08 | - | Årsstämma |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-27 | - | Bokslutskommuniké 2023 |
2023-11-09 | - | Kvartalsrapport 2023-Q3 |
2023-08-29 | - | Kvartalsrapport 2023-Q2 |
2023-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2023-05-09 | - | Årsstämma |
2023-05-09 | - | Kvartalsrapport 2023-Q1 |
2023-02-27 | - | Bokslutskommuniké 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-29 | - | Kvartalsrapport 2022-Q2 |
2022-05-03 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2022-05-02 | - | Årsstämma |
2022-05-02 | - | Kvartalsrapport 2022-Q1 |
2022-02-28 | - | Bokslutskommuniké 2021 |
2021-11-09 | - | Kvartalsrapport 2021-Q3 |
2021-08-24 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | Årsstämma |
2021-05-05 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2021-05-03 | - | Kvartalsrapport 2021-Q1 |
2021-04-19 | - | Extra Bolagsstämma 2021 |
2021-02-28 | - | Bokslutskommuniké 2020 |
2020-12-18 | - | Extra Bolagsstämma 2020 |
2020-11-09 | - | Kvartalsrapport 2020-Q3 |
2020-08-24 | - | Kvartalsrapport 2020-Q2 |
2020-06-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2020-06-22 | - | Årsstämma |
2020-05-04 | - | Kvartalsrapport 2020-Q1 |
2020-02-25 | - | Bokslutskommuniké 2019 |
2019-11-18 | - | Kvartalsrapport 2019-Q3 |
2019-08-26 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2019-05-06 | - | Årsstämma |
2019-05-06 | - | Kvartalsrapport 2019-Q1 |
2019-02-26 | - | Bokslutskommuniké 2018 |
2018-08-27 | - | Kvartalsrapport 2018-Q2 |
2018-05-08 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2018-05-07 | - | Årsstämma |
2018-02-27 | - | Bokslutskommuniké 2017 |
2017-09-25 | - | Extra Bolagsstämma 2017 |
2017-08-28 | - | Kvartalsrapport 2017-Q2 |
2017-04-06 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2017-04-05 | - | Årsstämma |
2017-02-22 | - | Bokslutskommuniké 2016 |
2016-10-26 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
2016-05-09 | - | Årsstämma |
2016-05-09 | - | Kvartalsrapport 2016-Q1 |
2016-02-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
2016-02-22 | - | Bokslutskommuniké 2015 |
2015-11-27 | - | Kvartalsrapport 2015-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
Redsense Medical announces that Peter Larsson is taking over as CFO, as Jennie Kardell decided to leave the company to pursue other opportunities. Peter Larsson will be joining the team as part-time CFO consultant.
Peter Larsson, born in 1969, has held multiple leading positions as CFO and CEO for a variety of companies across industries and geographies, including listed companies across markets. He has over 30 years of experience as CFO and a proven track record in scaling healthcare and technology companies. http://www.linkedin.com/in/peter-larsson/3843b835/
"We are thrilled that Peter is joining Redsense and are looking forward to a great cooperation. With extensive experience in MedTech and financial leadership, he brings a wealth of expertise to the team. We also thank Jennie Kardell for her contributions as both CFO and interim-CEO, and wish her the best of luck in her future endeavours" says Sebastien Bollue, CEO of Redsense Medical AB.
The company will also have additional support from a Postdoc intern from Karolinska Institute and a master student from Halmstad University, who will both assist the company on a part-time basis. Redsense participated in Karolinska Institute's Internship Program HT24, and hired a part-time Postdoc who is assisting the company during 6 months in health economics research, communication, and regulatory affairs. The program is co-financed by Karolinska Institute career services and Redsense. The part-time master student from Halmstad University will also assist with commercial operations such as supply chain management, quality management, and sustainability issues.
"We are excited to welcome our new team members; their expertise will strengthen our operations and support our continued growth. We remain committed to advancing Redsense and creating lasting value."
- Sebastien Bollue, CEO of Redsense Medical AB.
Contact information
For more information, please contact:
Sebastien Bollue, CEO
Telephone: +46 72-171 1264
E-mail: sebastien.bollue (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862